FOR IMMEDIATE RELEASE:
DANVILLE, PA -- Adam Buchanan, M.S., M.PH, has been named to the board of directors of the American Board of Genetic Counseling (ABGC).
The ABGC sets standards for certifying genetic counselors and provides leadership in education and promotion surrounding the value of certified genetic counselors. Mr. Buchanan will begin a four-year term with the Board starting in January 2017.
He is an assistant professor at the Genomic Medicine Institute at Geisinger Health System, where he is involved in the program to return important genomic findings to participants in Geisinger’s MyCode Community Health Initiative. Mr. Buchanan’s research interests include investigating questions about the delivery, follow-up care and support structures needed in large-scale genetic programs.
He is both a licensed and certified genetic counselor. He was previously a research scientist at the Duke Cancer Institute in Durham, N.C. Mr. Buchanan has been an ABGC Diplomate since 2005 and has served as an ABGC Item Writer, developing exam questions. He received his master of science in Genetic Counseling at the University of North Carolina at Greensboro.
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a Research Institute and the Geisinger Commonwealth School of Medicine. With nearly 24,000 employees and more than 1,700 employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at Facebook, Instagram, LinkedIn and Twitter.